Published in Br J Ophthalmol on October 01, 2005
Role of the retinal vascular endothelial cell in ocular disease. Prog Retin Eye Res (2012) 0.99
Biologic agents in inflammatory eye disease. J Ophthalmic Vis Res (2011) 0.90
Interferon-beta and adhesion molecules (E-selectin and s-intracellular adhesion molecule-1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling. Clin Exp Immunol (2007) 0.86
Ischemic retinal vasculitis and its management. J Ophthalmol (2014) 0.86
Uveitis and neurologic diseases: an often overlooked relationship. Wien Klin Wochenschr (2006) 0.86
Interferons and their potential in the treatment of ocular inflammation. Clin Ophthalmol (2009) 0.84
Ipsilateral uveitis and optic neuritis in multiple sclerosis. Mult Scler Int (2012) 0.82
MRI findings of elevated intracranial pressure in cerebral venous thrombosis versus idiopathic intracranial hypertension with transverse sinus stenosis. Neuroophthalmology (2013) 0.81
Pharmacotherapy for uveitis: current management and emerging therapy. Clin Ophthalmol (2014) 0.81
Etiology and treatment of the inflammatory causes of cystoid macular edema. J Inflamm Res (2009) 0.79
Systemic treatments for noninfectious vitreous inflammation. Mediators Inflamm (2013) 0.78
[Janus-faced?: Effects and side-effects of interferon therapy in ophthalmology]. Ophthalmologe (2011) 0.77
A review and update on orphan drugs for the treatment of noninfectious uveitis. Clin Ophthalmol (2017) 0.75
Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis. Turk J Ophthalmol (2016) 0.75
Systemic treatment of vitreous inflammation. Mediators Inflamm (2012) 0.75
Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a. Graefes Arch Clin Exp Ophthalmol (2014) 0.75
Alemtuzumab-induced remission of multiple sclerosis-associated uveitis. Int Ophthalmol (2016) 0.75
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol (1987) 5.13
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS. Neurology (2001) 4.69
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med (2000) 4.50
The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology (1997) 3.29
Lack of evidence for use of glatiramer acetate in multiple sclerosis. Lancet Neurol (2004) 2.70
Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur J Immunol (1971) 1.94
Uveitis and systemic disease. Br J Ophthalmol (1992) 1.88
Effect of type I interferon on experimental autoimmune uveoretinitis in rats. Ocul Immunol Inflamm (1998) 1.76
Long-term visual outcome and complications associated with pars planitis. Ophthalmology (1993) 1.72
Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology (1999) 1.11
Uveitis, perivenous sheathing and multiple sclerosis. Neurology (1978) 1.06
The incidence of uveitis in multiple sclerosis. Am J Ophthalmol (1966) 1.04
Symptomatic intraocular inflammation in multiple sclerosis. Clin Experiment Ophthalmol (2000) 1.00
Sheathing of the retinal veins in multiple sclerosis. Review of pertinent literature. Mayo Clin Proc (1972) 0.98
Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis. Clin Experiment Ophthalmol (2000) 0.97
Therapy with glatiramer acetate for multiple sclerosis. Cochrane Database Syst Rev (2004) 0.95
Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol (2001) 0.92
Uveitis. A series of 368 patients. Trans Ophthalmol Soc U K (1976) 0.90
Myelin basic protein specific T-helper cells induce experimental anterior uveitis. J Neurosci Res (1996) 0.90
Uveitis in association with multiple sclerosis. Br J Ophthalmol (1972) 0.88
Chronic granulomatous anterior uveitis associated with multiple sclerosis. Graefes Arch Clin Exp Ophthalmol (1993) 0.80
Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). Curr Eye Res (2000) 0.80
Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology (2001) 3.41
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Immune reconstitution inflammatory syndrome after withdrawal of natalizumab? Neurology (2010) 2.36
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol (2003) 2.20
Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science (1996) 1.76
Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci (2010) 1.75
[Amendment of the structural quality for inpatient rheumatology. A forward-looking concept]. Z Rheumatol (2011) 1.74
Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology (2000) 1.73
Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases. Arthritis Rheum (2002) 1.51
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci (2011) 1.49
Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone (2003) 1.48
Haemodilution with dextran 40 and hydroxyethyl starch and its effect on cerebral microcirculation. J Neurol (1989) 1.43
[Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid]. Klin Monbl Augenheilkd (2001) 1.40
[Uveitis in childhood sarcoidosis]. Klin Monbl Augenheilkd (2005) 1.39
Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol (2014) 1.38
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Small animal bone healing models: standards, tips, and pitfalls results of a consensus meeting. Bone (2011) 1.24
Anti-endothelial serum antibodies in a patient with Susac's syndrome. J Neurol Sci (2009) 1.21
["Herpetic keratitis". Various expressions require different therapeutic approaches]. Ophthalmologe (2011) 1.19
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature. Mult Scler (2011) 1.16
Biodegradable poly(D,L-lactide) coating of implants for continuous release of growth factors. J Biomed Mater Res (2001) 1.15
Corneal calcification following intensified treatment with sodium hyaluronate artificial tears. Br J Ophthalmol (2006) 1.15
Two cases of benign neuromyelitis optica in patients with celiac disease. J Neurol (2009) 1.14
A new model of implant-related osteomyelitis in rats. J Biomed Mater Res B Appl Biomater (2003) 1.13
Antibodies to CV2/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg (2011) 1.10
GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis. J Neuroimmunol (2013) 1.10
Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid. AIDS Res Hum Retroviruses (1992) 1.09
16S rDNA-based identification of bacteria from conjunctival swabs by PCR and DGGE fingerprinting. Invest Ophthalmol Vis Sci (2001) 1.08
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry (2008) 1.08
Serum neuron-specific enolase as early predictor of outcome after cardiac arrest. Crit Care Med (1997) 1.08
Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus. Lupus (2006) 1.06
Macrophage-depletion influences the course of murine HSV-1 keratitis. Curr Eye Res (2000) 1.05
Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology (1997) 1.04
'Noteomielite' accompanied by acute amaurosis (1844). An early case of neuromyelitis optica. J Neurol Sci (2011) 1.03
Acute disseminated encephalomyelitis after parenteral therapy with herbal extracts: a report of two cases. J Neurol Neurosurg Psychiatry (2000) 1.03
[Vision-threatening complications in childhood uveitis]. Ophthalmologe (2005) 1.02
Rodent animal models of delayed bone healing and non-union formation: a comprehensive review. Eur Cell Mater (2013) 1.02
Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry. J Neurol Sci (2012) 1.02
Influence of age on the cell biological characteristics and the stimulation potential of male human tenocyte-like cells. Eur Cell Mater (2012) 1.02
Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation (2000) 1.00
Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol (2009) 1.00
Susac's syndrome: improvement with combined antiplatelet and calcium antagonist therapy. Stroke (1996) 0.98
Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells. J Immunol (1993) 0.98
Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study. Br J Ophthalmol (1998) 0.97
Infusion of recombinant tissue plasminogen activator for treatment of basilar artery occlusion. Stroke (1990) 0.95
Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers. Vasa (1998) 0.95
Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone (2005) 0.95
Transscleral diode laser cyclophotocoagulation as primary surgical treatment for secondary glaucoma in juvenile idiopathic arthritis: high failure rate after short term follow up. Br J Ophthalmol (2006) 0.94
An early case of neuromyelitis optica: on a forgotten report by Jacob Lockhart Clarke, FRS. Mult Scler (2011) 0.94
Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist? Ann Rheum Dis (2005) 0.94
Characterization of tendon cell cultures of the human rotator cuff. Eur Cell Mater (2010) 0.94
Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone (2009) 0.94
Distress, depression and coping in HLA-B27-associated anterior uveitis with focus on gender differences. Br J Ophthalmol (2010) 0.94
Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye (Lond) (2008) 0.93
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Mult Scler (2012) 0.92
Central visual field impairment during and following cystoid macular oedema. Br J Ophthalmol (2007) 0.92
Effect of mechanical stimulation on osteoblast- and osteoclast-like cells in vitro. Cells Tissues Organs (2008) 0.92
Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy. Neurology (2001) 0.92
[Canaloplasty and transient anterior chamber haemorrhage: a prognostic factor?]. Klin Monbl Augenheilkd (2010) 0.91
Critical vasospasm during fingolimod (FTY720) treatment in a patient with multiple sclerosis. Neurology (2010) 0.91
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. J Neurol (2012) 0.91
Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease. Rheumatology (Oxford) (2004) 0.90
[Anti-TNF-α treatment for uveitis. Analysis of the current situation]. Ophthalmologe (2011) 0.90
Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome. J Neuroimmunol (2010) 0.90
The effect of zoledronic acid incorporated in a poly(D,L-lactide) implant coating on osteoblasts in vitro. J Biomed Mater Res A (2007) 0.90
In vivo comparison of zidovudine resistance mutations in blood and CSF of HIV-1-infected patients. Neurology (1993) 0.89
A new electrochemically graded hydroxyapatite coating for osteosynthetic implants promotes implant osteointegration in a rat model. J Biomed Mater Res (2002) 0.88
Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Scand J Rheumatol (2007) 0.88
[Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks]. Ophthalmologe (2007) 0.87
MMF and eye disease. Lupus (2005) 0.87
Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis. Br J Ophthalmol (2010) 0.86
Musculoskeletal and neuropsychiatric manifestations are the main source of persisting affection and organ damage in a German population of patients with systemic lupus erythematosus. Scand J Rheumatol (2006) 0.85
HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alpha. Ann Rheum Dis (2001) 0.85
Gene delivery to the corneal endothelium. Am J Respir Crit Care Med (2000) 0.85
[Inflammatory choroidal neovascularisations]. Klin Monbl Augenheilkd (2012) 0.85
[Diagnosis and treatment of neuromyelitis optica. Consensus recommendations of the Neuromyelitis Optica Study Group]. Nervenarzt (2011) 0.85
Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages. Exp Eye Res (2001) 0.84
On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica. J Neurol (2012) 0.84
Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens (2001) 0.84
Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma. Int J Hematol (2011) 0.84
[Susac syndrome: an interdisciplinary challenge]. Nervenarzt (2011) 0.84
[Radial optic neurotomy for ischemic central retinal vein occlusion]. Klin Monbl Augenheilkd (2007) 0.84
The role of macrophages in the pathogenesis of HSV-1 induced chorioretinitis in BALB/c mice. Invest Ophthalmol Vis Sci (1994) 0.83
Diagnosis of cytomegalovirus encephalitis in patients with AIDS by quantitation of cytomegalovirus genomes in cells of cerebrospinal fluid. Neurology (1998) 0.83
[Evidence and consensus based treatment guidelines 2010 for juvenile idiopathic arthritis by the German Society of Paediatric Rheumatology]. Klin Padiatr (2011) 0.83
Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature. Clin Exp Rheumatol (2005) 0.83
Adenoviral p53 gene transfer inhibits human Tenon's capsule fibroblast proliferation. Br J Ophthalmol (2005) 0.83
Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury (2007) 0.83
Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up. Ann Rheum Dis (2005) 0.83